Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 1 , Pages 27-34 , February 2010

Role of radiotherapy in the treatment of lymphomas of the gastrointestinal tract

  • Berthe M.P. Aleman, MD, PhD (Radiation Oncologist (Staff Position) at Specialised Cancer Institute)

      Affiliations

    • Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 205122124; fax: +31 206691101.
    • ,
  • Rick L.M. Haas, MD, PhD (Radiation Oncologist (Staff Position) at Specialised Cancer Institute)

      Affiliations

    • Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • Richard W.M. van der Maazen, MD, PhD (Radiation Oncologist (Staff Position) at University Hospital)

      Affiliations

    • Department of Radiotherapy, Radboud University, Nijmegen Medical Centre, Geert Grooteplein 10, 6500 HB Nijmegen, The Netherlands
    • Tel.: +31 243614515; fax: +31 243568350.

References 

  1. Gustafsson BI, Siddique L, Chan A, et al. Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy. Int J Oncol. 2008;33:1121–1131
  2. Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–3873
  3. Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma–results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3874–3883
  4. Taal BG, Boot H, van Heerde P, et al. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept [see comments]. Gut. 1996;39:556–561
  5. Burgers JM, Taal BG, van Heerde P, et al. Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach. Radiother Oncol. 1988;11:319–326
  6. Taal BG, Burgers JM, van HP, et al. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol. 1993;4:839–846
  7. Verheij M, Dewit LG, Valdes Olmos RA, et al. Evidence for a renovascular component in hypertensive patients with late radiation nephropathy. Int J Radiat Oncol Biol Phys. 1994;30:677–683
  8. Cogliatti SB, Schmid U, Schumacher U, et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology. 1991;101:1159–1170
  9. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 1992;102:1628–1638
  10. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma [see comments]. Lancet. 1991;338:1175–1176
  11. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue type after eradication of Helicobacter pylori [see comments]. Lancet. 1993;342:575–577
  12. Ruskoné-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti- Helicobacter pylori treatment. Gut. 2001;48:297–303
  13. Bayerdörffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group [see comments]. Lancet. 1995;345:1591–1594
  14. de Jong D, Aleman BM, Taal BG, et al. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol. 1999;10:275–280
  15. Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology. 2000;119:1191–1202
  16. Hammel P, Haioun C, Chaumette MT, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa- associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol. 1995;13:2524–2529
  17. Morgner A, Schmelz R, Thiede C, et al. Therapy of gastric mucosa associated lymphoid tissue lymphoma. World J Gastroenterol. 2007;13:3554–3566
  18. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16:1916–1921
  19. Liu H, Ruskoné-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet. 2001;357:39–40
  20. Liu H, Ye H, Ruskoné-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology. 2002;122:1286–1294
  21. Yahalom J, Schechter NR, Gonzales M, et al. H.Pylori-independant MALT lymphoma of the stomach: 10-year experience with 51 patients treated with radiation alone. Ann Oncol. 2002;13(Supplement 2):43
  22. Vrieling C, de Jong D, Boot H, et al. Long-term results of stomach-conserving therapy in gastric MALT lymphoma. Radiother Oncol. 2008;87:405–411
  23. Park W, Chang SK, Yang WI, et al. Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma. Int J Radiat Oncol Biol Phys. 2004;58:1480–1486
  24. Della BC, Hunt M, Furhang E, et al. Radiation treatment planning techniques for lymphoma of the stomach. Int J Radiat Oncol Biol Phys. 2005;62:745–751
  25. van der Geld YG, Senan S, van Sornsen de Koste JR, et al. A four-dimensional CT-based evaluation of techniques for gastric irradiation. Int J Radiat Oncol Biol Phys. 2007;69:903–909
  26. Lawrence TS, Robertson JM, Anscher MS, et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31:1237–1248
  27. Haas RL, Poortmans P, de JD, et al. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Eur J Cancer. 2005;41:1724–1730
  28. Swerdlow S, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4 ed. Lyon: 2008.
  29. Aviles A, Nambo MJ, Neri N, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg. 2004;240:44–50
  30. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–242
  31. Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;7:379–391
  32. Persky DO, Unger JM, Spier CM, et al. Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. J Clin Oncol. 2008;26:2258–2263
  33. Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005;23:7050–7059
  34. Ruskoné-Fourmestraux A, Aegerter P, Delmer A, et al. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterology. 1993;105:1662–1671
  35. Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys. 1995;31:1249–1256
  36. Raderer M, Streubel B, Wohrer S, et al. Metachronous gastric MALT lymphoma and early gastric cancer. Ann Oncol. 2006;17:724
  37. Morgner A, Miehlke S, Stolte M, et al. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol. 2001;7:248–253
  38. Hamaloglu E, Topaloglu S, Ozdemir A, et al. Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: A review of the literature. World J Gastroenterol. 2006;12:3564–3574
  39. Ha CS, Cho MJ, Allen PK, et al. Primary non-Hodgkin lymphoma of the small bowel. Radiology. 1999;211:183–187
  40. Yamashita H, Nakagawa K, Asari T, et al. Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study. Radiother Oncol. 2008;87:412–417
  41. Amouri A, Chtourou L, Mnif L, et al. MALT lymphoma of the rectum: a case report treated by radiotherapy. Cancer Radiother. 2009;13:61–64
  42. Ibrahim EM, Ezzat AA, El-Weshi AN, et al. Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol. 2001;12:53–58
  43. Lee J, Kim WS, Kim K, et al. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res. 2007;31:359–364
  44. Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. Semin Oncol. 1999;26:324–337
  45. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21:4157–4164
  46. Willich NA, Reinartz G, Horst EJ, et al. Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study. Int J Radiat Oncol Biol Phys. 2000;46:895–901

PII: S1521-6918(09)00155-3

doi: 10.1016/j.bpg.2009.12.002

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 1 , Pages 27-34 , February 2010

Article Tools

* Image Usage & Resolution